期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
应用达格列净加沙库巴曲缬沙坦治疗2型糖尿病合并心力衰竭的效果探讨观察 被引量:3
1
作者 王红红 范维勇 《糖尿病新世界》 2023年第10期63-65,84,共4页
目的观察应用达格列净加沙库巴曲缬沙坦治疗2型糖尿病合并心力衰竭的临床疗效。方法选取2020年1月—2021年1月期间在山东省滨州市无棣县人民医院心内科治疗的96例2型糖尿病合并心力衰竭患者为研究对象,按入院时间分为常规组(48例)和研究... 目的观察应用达格列净加沙库巴曲缬沙坦治疗2型糖尿病合并心力衰竭的临床疗效。方法选取2020年1月—2021年1月期间在山东省滨州市无棣县人民医院心内科治疗的96例2型糖尿病合并心力衰竭患者为研究对象,按入院时间分为常规组(48例)和研究组(48例)。常规组采用沙库巴曲缬沙坦联合二甲双胍缓释片治疗,研究组在常规组基础上联合达格列净治疗,对比两组患者血糖生化指标、不良反应发生率。结果研究组FPG、2 hPG、HbA1c、HOMA-β、HOMA-IR均优于常规组,差异有统计学意义(P<0.05)。研究组患者不良反应发生率(6.25%)低于常规组(29.16%),差异有统计学意义(P<0.05)。结论达格列净加沙库巴曲缬沙坦治疗2型糖尿病合并心力衰竭患者,可以降糖减脂,有效提升患者的生存质量。 展开更多
关键词 达格列净 沙库巴曲缬沙坦 2型糖尿病合 心力衰竭 临床疗效
下载PDF
中老年2型糖尿病合并高血压的相关影响因素分析 被引量:3
2
作者 秦铭健 《实用糖尿病杂志》 2020年第2期68-69,共2页
选择2014年1月至2015年9月30例中老年2型糖尿病患者为对照组,30例2型糖尿病合并高血压患者记为观察组。结果:观察组患者年龄、血尿酸(UA)、高密度脂蛋白(HDL)、以及纤维蛋白原(FIB)等数据均明显高于对照组(P<0.05);观察组患者空腹血... 选择2014年1月至2015年9月30例中老年2型糖尿病患者为对照组,30例2型糖尿病合并高血压患者记为观察组。结果:观察组患者年龄、血尿酸(UA)、高密度脂蛋白(HDL)、以及纤维蛋白原(FIB)等数据均明显高于对照组(P<0.05);观察组患者空腹血糖(FPG)、甘油三酯(TG)以及低密度脂蛋白(LDL)等指标水平明显低于对照组(P<0.05)。结论:年龄、血尿酸、高密度脂蛋白以及纤维蛋白原是2型糖尿病合并高血压疾病的危险致病因素。 展开更多
关键词 中老年 2型糖尿病合 高血压 相关影响因素
下载PDF
二甲双胍对2型糖尿病合并原发性亚临床甲状腺功能减退患者血清促甲状腺激素水平的影响 被引量:3
3
作者 姜鹤 刘铁群 《中国药物经济学》 2016年第3期33-34,共2页
目的探讨二甲双胍对2型糖尿病合并原发性亚临床甲状腺功能减退患者血清促甲状腺激素(TSH)水平的影响。方法选取2013年6月至2015年5月大连大学附属中山医院收治的125例2型糖尿病合并原发性亚临床甲状腺功能减退患者作为研究对象,按随机... 目的探讨二甲双胍对2型糖尿病合并原发性亚临床甲状腺功能减退患者血清促甲状腺激素(TSH)水平的影响。方法选取2013年6月至2015年5月大连大学附属中山医院收治的125例2型糖尿病合并原发性亚临床甲状腺功能减退患者作为研究对象,按随机数字表法将其分为观察组(63例)和对照组(62例)。观察组患者采用二甲双胍进行治疗,对照组患者口服左旋甲状腺素钠片,比较两组患者治疗前后的空腹血糖(FBG)值、餐后2 h血糖(2 h PBG)及血清TSH水平。结果治疗后,观察组患者的FBG、2 h PBG均明显低于对照组,差异均有统计学意义(均P<0.05);治疗后,观察组患者的血清TSH水平为(1.3±0.8)m IU/L,明显低于对照组的(1.8±1.7)m IU/L,差异有统计学意义(t=7.1042,P<0.05)。结论二甲双胍可有效改善2型糖尿病合并原发性亚临床甲状腺功能减退患者血清TSH水平,降低血糖值,是2型糖尿病合并原发性亚临床甲状腺功能减退患者的理想治疗药物。 展开更多
关键词 二甲双胍 2型糖尿病合 原发性亚临床甲状腺功能减退 促甲状腺激素
原文传递
降糖丸干预对2型糖尿病胰岛素敏感性的影响 被引量:3
4
作者 何劲 宋道飞 《湖北中医杂志》 2009年第7期20-21,共2页
目的观察降糖丸干预对2型糖尿病胰岛素敏感性的影响。方法64例分成两组,治疗组34例,给于降糖丸治疗,对照组30例,给于二甲双胍治疗。分别观察治疗前后血糖、胰岛素、血脂等指标。结果两组治疗后空腹及餐后血糖均改善,血游离脂肪酸明显下... 目的观察降糖丸干预对2型糖尿病胰岛素敏感性的影响。方法64例分成两组,治疗组34例,给于降糖丸治疗,对照组30例,给于二甲双胍治疗。分别观察治疗前后血糖、胰岛素、血脂等指标。结果两组治疗后空腹及餐后血糖均改善,血游离脂肪酸明显下降,治疗组优于对照组(P<0.05);胰岛素敏感性指数升高。结论降糖丸对有胰岛素抵抗因素的2型糖尿病治疗是有效的。 展开更多
关键词 2糖尿病 中西医给疗法 降糖丸 胰岛素敏感指数
下载PDF
血清中MANF、Nesfatin-1水平在T2DM合并NAFLD患者中的变化及其相关性研究
5
作者 汪惠敏 金国玺 +2 位作者 方言 朱闫慧 裴晓艳 《牡丹江医学院学报》 2023年第5期44-48,5,共6页
目的研究在2型糖尿病(Diabetes mellitus type 2,T2DM)合并非酒精性脂肪肝(Nonalcoholic fatty liver disease,NAFLD)患者中血清中脑星形细胞源性神经营养因子(midbrain astrocyte-derived neurotrophic factor,MANF)、人新饱食分子蛋白... 目的研究在2型糖尿病(Diabetes mellitus type 2,T2DM)合并非酒精性脂肪肝(Nonalcoholic fatty liver disease,NAFLD)患者中血清中脑星形细胞源性神经营养因子(midbrain astrocyte-derived neurotrophic factor,MANF)、人新饱食分子蛋白(Nesfatin-1,NES1)的变化及其与疾病严重程度的关系。方法选取由蚌埠医学院第一附属医院内分泌与代谢疾病科收治的符合诊断标准的149例T2DM患者作为研究对象,根据NAFLD诊断标准分为单纯T2DM组(B组,即肝脏无脂肪变性)和T2DM合并NAFLD组(C组);根据合并脂肪肝的严重程度将T2DM合并NAFLD组分为轻度脂肪变、中度脂肪变、重度脂肪变三个亚组;另外选择在本院进行健康查体的30例符合标准的志愿者作为健康对照组(A组);比较几组间血清MANF、Nesfatin-1、白介素6(interleukin-6,IL-6)及其他相关指标的水平变化,观察各组间指标是否有相关性。结果一般资料分析显示与A组、B组相比,C组在内脏脂肪、皮下脂肪、体重、BMI水平显著升高,差异有统计学意义(P<0.05);糖脂代谢指标分析显示,与A组相比,C组MANF、Nesfatin-1水平显著降低,IL-6水平显著升高,差异有统计学意义(P<0.05);组间比较结果示重度组MANF、Nesfatin-1水平低于轻度组与中度组,IL-6水平升高,差异有统计学意义(P<0.05);回归分析显示MANF、IL-6与T2DM合并NAFLD严重程度的密切相关,且MANF是疾病严重程度的保护性因素。结论血清MANF、Nesfatin-1可能参与T2DM合并NAFLD的发生发展且与脂肪肝的严重程度密切相关。 展开更多
关键词 MANF NESFATIN-1 IL-6 2型糖尿病合 酒精性脂肪肝
下载PDF
Interventions for self-management of type 2 diabetes:An integrative review 被引量:6
6
作者 Roger Carpenter Toni DiChiacchio Kendra Barker 《International Journal of Nursing Sciences》 CSCD 2019年第1期70-91,共22页
Background:Type 2 diabetes mellitus has been identified as one of the most challenging chronic illnesses to manage.Since the management of diabetes is mainly accomplished by patients and families,selfmanagement has be... Background:Type 2 diabetes mellitus has been identified as one of the most challenging chronic illnesses to manage.Since the management of diabetes is mainly accomplished by patients and families,selfmanagement has become the mainstay of diabetes care.However,a significant proportion of patients fail to engage in adequate self-management.A priority research question is how do interventions affect the self-management behaviors of persons with Type 2 diabetes?Purpose/Objectives:The purpose of this integrative review is to provide a summary and critique of interventions that support diabetes self-management in the patient with TypeⅡdiabetes mellitus.Design:An integrative review design,with a comprehensive methodological approach of reviews,allowing inclusion of experimental and non-experimental studies.Procedures:A comprehensive search was conducted via Ebscohost using databases of Academic Search Complete,CINAHL,Health Source:Nursing/Academic Edition,MEDLINE,PsycArtiCLES,and PsycInfo.The final number of papers used for this review were:motivational interviewing(6),peer support/coaching(10),problem solving therapy(3),technology-based interventions(30),lifestyle modification programs(7),patient education(11),mindfulness(3),and cognitive behavioral therapy(5).Results:Studies were examined from seventeen countries including a broad range of cultures and ethnicities.While interventions have shown mixed results in all interventional categories,many studies do support small to modest improvements in physiologic,behavioral,and psychological outcome measures.Considerable heterogeneity of interventions exists.The most commonly reported physiologic measure was HbA1c level.Outcome measures were collected mostly at 6 and 12 months.Duration of most research was limited to one year.Conclusions:Research exploring the impact of interventions for self-management has made major contributions to the care of persons with type 2 diabetes,from offering suggestions for improving care,to stimulating new questions for research.However,implications for clinical practice remain inconclusive,and limitations in existing research suggest caution in interpreting results of studies. 展开更多
关键词 Type 2 diabetes Interventions RESEARCH Integrative review
下载PDF
高血压合并2型糖尿病行吲达帕胺联合缬沙坦对血压与尿微量白蛋白的影响 被引量:3
7
作者 张青立 申姗姗 《医药论坛杂志》 2015年第6期150-152,共3页
目的观察高血压合并2型糖尿病行吲达帕胺联合缬沙坦对血压与尿微量白蛋白的影响。方法选取本院2013年1月—2014年6月收治的高血压合并2型糖尿病患者共86例,随机分为观察组与对照组;观察组43例予吲达帕胺联合缬沙坦治疗,对照组43例予吲... 目的观察高血压合并2型糖尿病行吲达帕胺联合缬沙坦对血压与尿微量白蛋白的影响。方法选取本院2013年1月—2014年6月收治的高血压合并2型糖尿病患者共86例,随机分为观察组与对照组;观察组43例予吲达帕胺联合缬沙坦治疗,对照组43例予吲达帕胺治疗;观察治疗前后两组血压、肾功能及血生化相关指标。结果观察组治疗后SBP、DBP均显著低于治疗前,差异有统计学意义(P<0.01);治疗后观察组SBP(130.14±7.69)mm Hg,DBP(75.15±6.65)mm Hg,均显著优于对照组(P<0.05);治疗后观察组m Alb(16.35±3.42)mg/g,BUN(5.12±1.03)mmol/L,Cr(96.58±7.21μmol/L)均显著优于对照组,差异有统计学意义(P<0.05);观察组治疗前后的血生化指标比较,差异无统计学意义(P>0.05)。结论高血压合并糖尿病行吲达帕胺联合缬沙坦治疗能够有效降低患者血压,恢复尿微量白蛋白水平,临床疗效显著。 展开更多
关键词 高血压2糖尿病 吲达帕胺 缬沙坦 血压 尿微量白蛋白
原文传递
Drug Therapy Monitoring in Patients with Type 2 Diabetes and Hypertension
8
作者 Jose Francisco Castro Bolivar Femando Martinez-Martinez Monica Ferrit-Martin 《Journal of Pharmacy and Pharmacology》 2017年第4期169-178,共10页
The aim of this paper is to detect, prevent and resolve DRP (drug-related problems) and NOM (negative outcomes associated with medication) in hospitalized patients with DM2 (type 2 diabetes) with HTN (hypertens... The aim of this paper is to detect, prevent and resolve DRP (drug-related problems) and NOM (negative outcomes associated with medication) in hospitalized patients with DM2 (type 2 diabetes) with HTN (hypertension) in a tertiary care clinic. Descriptive cross-sectional interventional study is used. DTM (drug therapy monitoring) was conducted in 73 patients using data obtained from clinical histories and interviews. NOM were detected based on symptoms and laboratory test results. The statistical significance was 0.05. It can be found that 23 DRP were detected, primarily in the category "likelihood of adverse effects" (30.43%) causing NOM in the "non-quantitative safety problem" category. The NOM detected were related to safety (62%), effectiveness (24.5%) and necessity (13.5%). Of the 68.57% of pharmacist interventions accepted, 48.57% were resolved and 20% were not resolved. A simple linear correlation (r = -0.34) analysis indicated a weak association between patient age and severity ofNOM. DTM made it'possible to detect suspected DRP and NOM, which were then prevented or resolved, improving the control of HTN and DM2 and helping ensure better drug therapy outcomes for patients. 展开更多
关键词 Drug therapy monitoring type 2 diabetes mellitus HYPERTENSION pharmacist intervention.
下载PDF
Alcohol consumption and metabolic syndrome among Shanghai adults: A randomized multistage stratified cluster sampling investigation 被引量:13
9
作者 Jian-Gao Fan Xiao-Bu Cai +3 位作者 Lui Li Xing-Jian Li Fei Dai Jun Zhu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第15期2418-2424,共7页
AIM: To examine the relations of alcohol consumption to the prevalence of metabolic syndrome in Shanghai adults. METHODS: We performed a cross-sectional analysis of data from the randomized multistage stratified clust... AIM: To examine the relations of alcohol consumption to the prevalence of metabolic syndrome in Shanghai adults. METHODS: We performed a cross-sectional analysis of data from the randomized multistage stratified cluster sampling of Shanghai adults, who were evaluated for alcohol consumption and each component of metabolic syndrome, using the adapted U.S. National Cholesterol Education Program criteria. Current alcohol consumption was defined as more than once of alcohol drinking per month. RESULTS: The study population consisted of 3953 participants (1524 men) with a mean age of 54.3 ± 12.1 years. Among them, 448 subjects (11.3%) were current alcohol drinkers, including 405 males and 43 females. After adjustment for age and sex, the prevalence of current alcohol drinking and metabolic syndrome in the general population of Shanghai was 13.0% and 15.3%, respectively. Compared with nondrinkers, the prevalence of hypertriglyceridemia and hypertension was higher while the prevalence of abdominal obesity, low serum high-density-lipoprotein cholesterol (HDL-C) and diabetes mellitus was lower in subjects who consumed alcohol twice or more per month, with a trend toward reducing the prevalence of metabolic syndrome. Among the current alcohol drinkers, systolic blood pressure, HDL-C, fastingplasma glucose, and prevalence of hypertriglyceridemia tended to increase with increased alcohol consumption. However, low-density-lipoprotein cholesterol concentration, prevalence of abdominal obesity, low serum HDL-C and metabolic syndrome showed the tendency to decrease. Moreover, these statistically significant differences were independent of gender and age.CONCLUSION: Current alcohol consumption is associated with a lower prevalence of metabolic syndrome irrespe- ctive of alcohol intake (g/d), and has a favorable influence on HDL-C, waist circumference, and possible diabetes mellitus. However, alcohol intake increases the likelihood of hypertension, hypertriglyceridemia and hyperglycemia. The clinical significance of these findings needs further investigation. 展开更多
关键词 ALCOHOL Metabolic syndrome Obesity Type2 diabetes EPIDEMIOLOGY Chinese
下载PDF
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 被引量:59
10
作者 Yoshihisa Takahashi Yurie Soejima Toshio Fukusato 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第19期2300-2308,共9页
Nonalcoholic fatty liver disease(NAFLD) is a condition in which excess fat accumulates in the liver of a patient without a history of alcohol abuse.Nonalcoholic steatohepatitis(NASH),a severe form of NAFLD,can progres... Nonalcoholic fatty liver disease(NAFLD) is a condition in which excess fat accumulates in the liver of a patient without a history of alcohol abuse.Nonalcoholic steatohepatitis(NASH),a severe form of NAFLD,can progress to liver cirrhosis and hepatocellular carcinoma.NAFLD is regarded as a hepatic manifestation of metabolic syndrome and incidence has been increasing worldwide in line with the increased prevalence of obesity,type 2 diabetes,and hyperlipemia.Animal models of NAFLD/NASH give crucial information,not only in elucidating pathogenesis of NAFLD/NASH but also in examining therapeutic effects of various agents.An ideal model of NAFLD/NASH should correctly reflect both hepatic histopathology and pathophysiology of human NAFLD/NASH.Animal models of NAFLD/NASH are divided into genetic,dietary,and combination models.In this paper,we review commonly used animal models of NAFLD/NASH referring to their advantages and disadvantages. 展开更多
关键词 Animal model Nonalcoholic fatty liver dis-ease Nonalcoholic steatohepatitis Metabolic syndrome HISTOPATHOLOGY
下载PDF
Way back for fructose and liver metabolism:Bench side to molecular insights 被引量:2
11
作者 Alba Rebollo Núria Roglans +1 位作者 Marta Alegret Juan C Laguna 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第45期6552-6559,共8页
The World Health Organization recommends that the daily intake of added sugars should make up no more than 10% of total energy.The consumption of sugarsweetened beverages is the main source of added sugars.Fructose,to... The World Health Organization recommends that the daily intake of added sugars should make up no more than 10% of total energy.The consumption of sugarsweetened beverages is the main source of added sugars.Fructose,together with glucose,as a component of high fructose corn syrups or as a component of the sucrose molecule,is one of the main sweeteners present in this kind of beverages.Data from prospective and intervention studies clearly point to high fructose consumption,mainly in the form of sweetened beverages,as a risk factor for several metabolic diseases in humans.The incidence of hypertension,nonalcoholic fatty liver disease(NAFLD),dyslipidemia(mainly hypertriglyceridemia),insulin resistance,type 2 diabetes mellitus,obesity,and the cluster of many of these pathologies in the form of metabolic syndrome is higher in human population segments that show high intake of fructose.Adolescent and young adults from lowincome families are especially at risk.We recently reviewed evidence from experimental animals and human data that confirms the deleterious effect of fructose on lipid and glucose metabolism.In this present review we update the information generated in the past 2 years about high consumption of fructose-enriched beverages and the occurrence of metabolic disturbances,especially NAFLD,type 2 diabetes mellitus,and metabolic syndrome.We have explored recent data from observational and experimental human studies,as well as experimental data from animal and cell models.Finally,using information generated in our laboratory and others,we provide a view of the molecular mechanisms that may be specifically involved in the development of liver lipid and glucose metabolic alterations after fructose consumption in liquid form. 展开更多
关键词 OBESITY Metabolic syndrome HYPERTENSION DYSLIPIDEMIA Nonalcoholic fatty liver disease Clinicalstudies Experimental studies Sweetened beverages
下载PDF
Effects of Mo-Rubbing abdomen manipulation on glucose metabolism and inflammatory factors in rats with type 2 diabetes mellitus 被引量:1
12
作者 XIE Zhouyu XU Jingsong +2 位作者 KONG Xintian WU Yunchuan YANG Yanping 《Journal of Acupuncture and Tuina Science》 CSCD 2022年第5期354-362,共9页
Objective To observe the effect of Mo-Rubbing abdomen manipulation on glucose metabolism and inflammatory factors in rats with type 2 diabetes mellitus(T2DM).Methods Sixty Sprague-Dawley rats were randomly divided int... Objective To observe the effect of Mo-Rubbing abdomen manipulation on glucose metabolism and inflammatory factors in rats with type 2 diabetes mellitus(T2DM).Methods Sixty Sprague-Dawley rats were randomly divided into a normal group(n=10)and a group for modeling(n=50)using the random number table method.Rats in the group for modeling were induced to form T2DM models by a high-sugar and high-fat diet combined with intraperitoneal injection of streptozotocin.Thirty successfully modeled rats were randomly divided into a model group,a Mo-Rubbing abdomen group,and a metformin group,with 10 rats in each group.Rats in the normal group and the model group received no intervention,those in the Mo-Rubbing abdomen group received Mo-Rubbing abdomen manipulation,and those in the metformin group received metformin by gavage.After 8-week intervention,fasting insulin(FINS),fasting plasma glucose(FPG),homeostasis model assessment for insulin resistance(HOMA-IR)and area under the curve at the oral glucose tolerance test(AUC-OGTT),as well as serum inflammatory factors interleukin(IL)-1β,IL-6,and tumor necrosis factor(TNF)-αwere detected,and the morphological changes of the pancreas were also observed.Results After the 8-week intervention,the levels of FINS,FPG,HOMA-IR,and AUC-OGTT of rats in the Mo-Rubbing abdomen group were significantly lower than those in the model group(P<0.05);the pancreatic injury degree in the Mo-Rubbing abdomen group and the metformin group was lower than that in the model group.Compared with the model group,the serum IL-1β,IL-6,and TNF-αlevels of rats in the Mo-Rubbing abdomen group were significantly decreased(P<0.05),and the serum IL-1βand TNF-αlevels of the metformin group showed a downward trend;the serum IL-6 and TNF-αlevels in the Mo-Rubbing abdomen group were significantly lower than those in the metformin group(P<0.01).There was a significant positive correlation between FPG with IL-1β,IL-6,and TNF-αin the T2DM rats(P<0.01).Conclusion Mo-Rubbing abdomen manipulation reduces the inflammatory response and improves the morphological changes of the pancreas in T2DM rats,thereby achieving the effect of lowering blood glucose. 展开更多
关键词 TUINA MASSAGE Mo-Rubbing Manipulation Diabetes Mellitus Type 2 Inflammatory Factors Carbohydrate Metabolism
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部